GENIALL

• Research type

  Research Study

• Full title

  LPLD Registry, observational longitudinal pharmaco-epidemiologic study in lipoprotein lipase deficient (LPLD) patients, either treated or not treated with alipogene tiparvovec (Glybera®)

• IRAS ID

  150258

• Contact name

  Handrean Soran

• Contact email

  handrean.soran@mft.nhs.uk

• Sponsor organisation

  uniQure biopharma B.V.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  14/NW/0351

• Date of REC Opinion

  23 Jul 2014

• REC opinion

  Further Information Favourable Opinion